Personalised Breast Care in Warwickshire
Book OnlineContact Us
News

What is the Oncotype DX test and how is it used to improve breast cancer outcomes?

Oncotype DX is a genetic test that can help predict the likelihood of breast cancer recurrence in women with early-stage, hormone-receptor-positive, HER2-negative breast cancer. It can be used to guide treatment decisions, and potentially spare some women from unnecessary chemotherapy. It is an important tool for personalising breast cancer treatment and improving patient outcomes.

read more

Breast screening, mammograms and implants

Breast screening using mammograms can detect breast cancer at a very early stage and is offered to women aged 50-70 every 3 years on the NHS. In some countries, such as the USA, breast screening starts at age 40 and is recommended yearly. Breast screening reduces the...

read more